60 Degrees Pharmaceuticals, Inc. SXTP 深 沪
等待开盘 02-11 09:30:00 美东时间
4.05
-0.060
-1.46%
华盛通- 最 高4.12
- 今 开4.03
- 成交量 4.04万股
- 最 低 3.82
- 昨 收 4.11
- 总市值 521.31万
- 52周最高 17.68
- 市盈率 静 --
- 换手率 3.14%
- 52周最低 1.36
- 委 比 17.70%
- 总股本 128.72万
- 历史最高 2076.00
- 量 比 0.35
- 振 幅 7.30%
- 历史最低 1.36
- 每 手 1
- 风险率 2.79%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多60 Degrees Pharma shares are trading lower. The company announced a partnership with GoodRx to offer eligible consumers savings of up to 30% on ARAKODA.
60 Degrees Pharma shares are trading lower. The company announced a partnership...
02-03 03:00
美股大行评级 | 瑞穗上调希捷科技、西部数据、CoreWeave目标价；Trade Desk、W.R. Berkley遭多家大行下调目标价
今日重点评级关注：瑞穗：维持Syndax制药"跑赢大市"评级，目标价从410美元升至600美元；HC Wainwright & Co.：维持60 Degrees Pharmaceuticals, Inc."买入"评级，目标价从6美元升至24美元
01-28 10:59
60 Degrees Pharmaceuticals shares are trading higher after the company announced a partnership with Runway Health to expand pre-departure access to ARAKODA.
60 Degrees Pharmaceuticals shares are trading higher after the company announce...
01-22 21:07
60 Degrees Pharmaceuticals Identifies Babesia Parasite In 24% Of Participants In Group Of 50 Patients With Chronic Fatigue
60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ("60 Degrees Pharma" or the "Company"), a pharmaceutical company focused on developing new medicines for vector-borne disease, today announced that infection
2025-12-29 21:11
60 Degrees Pharma To Expand ARAKODA Sales And Marketing, Adding Reps, GoodRx Partnership And Enhanced Digital Campaign
6-month commercial pilot demonstrated increasing demand among prescribersExpansion plan includes doubling the number of sales reps, a new GoodRx partnership, and enhanced digital marketing campaignAdditional clinical
2025-12-11 21:19
美股大行评级 | 美银证券下调哔哩哔哩目标价至31美元；高盛下调诺和诺德目标价至54美元
今日重点评级关注：Benchmark：维持Grupo Televisa"买入"评级，目标价从9美元升至10美元；Truist Securities：维持迪尔股份"买入"评级，目标价从609美元升至612美元
2025-12-01 14:33
Ascendiant Capital Maintains Buy on 60 Degrees, Lowers Price Target to $2.8
Ascendiant Capital analyst Lucas Ward maintains 60 Degrees (NASDAQ:SXTP) with a Buy and lowers the price target from $3 to $2.8.
2025-11-28 18:57
美股大行评级 | 花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级
花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级>>
2025-11-17 10:49
HC Wainwright & Co. Assumes 60 Degrees at Buy, Announces Price Target of $6
HC Wainwright & Co. analyst Matthew Keller assumes 60 Degrees (NASDAQ:SXTP) with a Buy rating and announces Price Target of $6.
2025-11-14 20:48
60 Degrees Q3 EPS $(0.66) Beats $(1.21) Estimate, Sales $437.602K Beat $400.000K Estimate
60 Degrees (NASDAQ:SXTP) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(1.21) by 45.45 percent. This is a 85.81 percent increase over losses of $(4.65) per share from the
2025-11-14 02:54
